Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 9151-9160 Newer>

Chemistry World September 10, 2015 Katrina Megget	Merger fever sweeps pharma Cheap financing, among other factors, is allowing companies to stock their drug pipelines through acquisitions
Chemistry World September 7, 2015	Cancer Drugs Fund axes 23 treatments The Cancer Drugs Fund, which covers the cost of some cancer treatments that are not currently available on the National Health Service, has cut 23 treatments -- involving 16 drugs.
Chemistry World September 4, 2015 Matthew Gunther	Novartis to buy experimental MS drug from GSK in $1bn deal Currently in Phase II trials, the injectable drug ofatumumab, promoted under the brand name Arzerra, is an antibody that attacks specific proteins in the immune system.
Chemistry World September 4, 2015 Matthew Gunther	US regulator reprimands Cepheid for norovirus diagnosis tool quality The US Food and Drug Administration has admonished the molecular diagnostics company Cepheid for failing to maintain good manufacturing practices.
Chemistry World September 1, 2015 Rebecca Trager	FDA takes action to remove biosimilars roadblock In a move expected to facilitate the entry of biosimilar drugs into the US market, the US Food and Drug Administration has proposed a system for naming such copycat versions of biological drugs.
Information Today September 1, 2015	InfoDesk Plans New Version of PipelinePlus Pipeline Plus simplifies drug pipeline searching and provides federated results and related drug news on a single platform.
Fast Company Neal Ungerleider	Why Kim Kardashian's Instagram Post Was In Violation Of FDA Rules Her paid endorsement did not make mandatory statements about Diclegis' side effects and comply with the same rules that require spoken disclaimers at the close of television commercials for prescription drugs.
Chemistry World August 27, 2015 Phillip Broadwith	Job cuts at Lundbeck and DSM Specialist brain disease drugmaker Lundbeck and materials and life sciences firm DSM are both cutting staff in major restructuring efforts to cut costs and improve profitability.
Chemistry World August 27, 2015 Phillip Broadwith	Drugs in a class of their own In the last month, three drugs in new therapeutic classes have been approved for cardiovascular diseases.
Chemistry World August 26, 2015 Sarah Houlton	Female sexual desire drug approved Almost five years after Boehringer Ingelheim stopped development on the female hypoactive sexual desire disorder treatment flibanserin, it has been approved by the US Food and Drug Administration.
<Older 9151-9160 Newer> Return to current articles.